作者根据181例白血病患者的临床及尸检资料分析发现,有些患者发生致命性肺水肿的原因不明,但认为会与静脉应用阿糖胞苷(Ara—C)有关。181例白血病中,女87例,男94例,年龄14月～85岁(中数39岁),类型有急粒或急粒—单、急淋、急单、慢粒或慢粒—单、慢淋、慢单、浆细胞性及红白血病等。93例(51%)曾接受过24～72小时的静脉应用 Based on clinical and autopsy data from 181 patients with leukemia, the authors found that the cause of fatal pulmonary edema in some patients was unknown, but it is thought to be associated with intravenous Ara-C. Of the 181 leukemia patients, 87 were female and 94 were male, ranging in age from 14 months to 85 years (median 39 years). They were acute or acute - Slow drench, slow one, plasma cell and erythroleukemia and so on. Ninety-three (51%) patients had received intravenous use for 24 to 72 hours